Role of soluble triggering receptor expressed on myeloid cells-1 for diagnosing ventilator-associated pneumonia after cardiac surgery: an observational study

被引:10
作者
Matsuno, Alessandra K. [1 ]
Carlotti, Ana P. C. P. [1 ,2 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Div Pediat Crit Care Med, BR-14049 Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Dept Pediat, BR-14049900 Ribeirao Preto, SP, Brazil
来源
BMC CARDIOVASCULAR DISORDERS | 2013年 / 13卷
关键词
Triggering receptor expressed on myeloid cells-1; Ventilator-associated pneumonia; Diagnosis; Cardiac surgery; Postoperative; PROCALCITONIN; CHILDREN; SEPSIS; LUNG;
D O I
10.1186/1471-2261-13-107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The diagnosis of ventilator-associated pneumonia (VAP) is a challenge, particularly after cardiac surgery. The use of biological markers of infection has been suggested to improve the accuracy of VAP diagnosis. We aimed to evaluate the usefulness of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in the diagnosis of VAP following cardiac surgery. Methods: This was a prospective observational cohort study of children with congenital heart disease admitted to the pediatric intensive care unit (PICU) after surgery and who remained intubated and mechanically ventilated for at least 24 hours postoperatively. VAP was defined by the 2007 Centers for Disease Control and Prevention criteria. Blood, modified bronchoalveolar lavage (mBAL) fluid and exhaled ventilator condensate (EVC) were collected daily, starting immediately after surgery until the fifth postoperative day or until extubation for measurement of sTREM-1. Results: Thirty patients were included, 16 with VAP. Demographic variables, Pediatric Risk of Mortality (PRISM) and Risk Adjustment for Congenital Heart Surgery (RACHS)-1 scores, duration of surgery and length of cardiopulmonary bypass were not significantly diferent in patients with and without VAP. However, time on mechanical ventilation and length of stay in the PICU and in the hospital were significantly longer in the VAP group. Serum and mBAL fluid sTREM-1 concentrations were similar in both groups. In the VAP group, 12 of 16 patients had sTREM-1 detected in EVC, whereas it was undetectable in all but two patients in the non-VAP group over the study period (p = 0.0013) (sensitivity 0.75, specificity 0.86, positive predictive value 0.86, negative predictive value 0.75, positive likelihood ratio (LR) 5.25, negative LR 0.29). Conclusion: Measurement of sTREM-1 in EVC may be useful for the diagnosis of VAP after cardiac surgery.
引用
收藏
页数:7
相关论文
共 22 条
  • [1] Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection
    Adib-Conquy, Minou
    Monchi, Mehran
    Goulenok, Cyril
    Laurent, Ivan
    Thuong, Marie
    Cavaillon, Jean-Marc
    Adrie, Christophe
    [J]. SHOCK, 2007, 28 (04): : 406 - 410
  • [2] Diagnostic Implications of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in BAL Fluid of Patients With Pulmonary Infiltrates in the ICU
    Anand, Nitin J.
    Zuick, Scott
    Klesney-Tait, Julia
    Kollef, Marin H.
    [J]. CHEST, 2009, 135 (03) : 641 - 647
  • [3] Triggering Receptor Expressed on Myeloid Cell 1
    Barraud, Damien
    Gibot, Sebastien
    [J]. CRITICAL CARE CLINICS, 2011, 27 (02) : 265 - +
  • [4] TREM-1 amplifies inflammation and is a crucial mediator of septic shock
    Bouchon, A
    Facchetti, F
    Weigand, MA
    Colonna, M
    [J]. NATURE, 2001, 410 (6832) : 1103 - 1107
  • [5] The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children
    Brix-Christensen, V
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (06) : 671 - 679
  • [6] Ventilator-associated pneumonia
    Chastre, J
    Fagon, JY
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 867 - 903
  • [7] Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia
    Determann, RM
    Millo, JL
    Gibot, S
    Korevaar, JC
    Vroom, MB
    van der Poll, T
    Garrard, CS
    Schultz, MJ
    [J]. INTENSIVE CARE MEDICINE, 2005, 31 (11) : 1495 - 1500
  • [8] Clinical diagnosis of ventilator associated pneumonia revisited:: comparative validation using immediate post-mortem lung biopsies
    Fàbregas, N
    Ewig, S
    Torres, A
    El-Ebiary, M
    Ramirez, J
    de la Bellacasa, JP
    Bauer, T
    Cabello, H
    [J]. THORAX, 1999, 54 (10) : 867 - 873
  • [9] Lower respiratory viral illnesses - Improved diagnosis by molecular methods and clinical impact
    Garbino, J
    Gerbase, MW
    Wunderli, W
    Deffernez, C
    Thomas, Y
    Rochat, T
    Ninet, B
    Schrenzel, J
    Yerly, S
    Perrin, L
    Soccal, PM
    Nicod, L
    Kaiser, L
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (11) : 1197 - 1203
  • [10] Clinical review: Role of triggering receptor expressed on myeloid cells-1 during sepsis
    Gibot, S
    [J]. CRITICAL CARE, 2005, 9 (05): : 485 - 489